Mohan Venkadesan

Mohan Venkadesan

Building the Future of Preventive Eye Care

Mohan Venkadesan is building the next generation of preventive eye-care technologies by transforming unmet clinical challenges into scalable healthcare solutions.

Combining vision science, engineering, human-centred design and healthcare delivery, he develops evidence-based innovations that enable earlier detection, prevention and better management of vision conditions.

His flagship colour vision screening technology is a clinically validated, patent protected innovation, published in an international peer-reviewed journal and deployed across eye-care programmes, delivering results in under six seconds. The technology has contributed to screening over 1M+ children worldwide.

Mohan is now advancing the next generation of diagnostic and preventive vision technologies and collaborating with researchers, entrepreneurs, strategic partners and investors to build accessible, scalable solutions for the future of eye care.

Mohan Venkadesan

Children Screened

Screening Time achieved in clinical assessment

Tertiary Hospital deployments

Clinical Technologies Validated

Patents

Countries

Validated & Deployed Through Eye care Networks

Aravind Eye Care Systems
Carl Zeiss
Voluntary Health Services
Dr Schroffs New Delhi
Nepal Nethra Jyothi SANGH
Sankara-Nethralaya-Medical-Research-Foundation
Karpagam Hospital
Little Flower Eye Hospital
ESO
pENN
Tamilnadu Government
Orbis Eyecamps

“My journey began with treating patients and evolved into building independent healthcare technologies. I believe meaningful innovation starts with real clinical problems and succeeds only when it creates measurable impact.”

– Mohan Venkadesan

Currently Building : The Future of Preventive Eye Care

BODVS by Mohan Venkadesan

BioEyes Ophthalmic Digital Vision Screener (BODVS) is the foundation of a broader preventive eye care ecosystem, combining digital screening, intelligent assessment and accessible clinical workflows to enable earlier disease detection and intervention.

A New Approach to Preventive Screening

The platform aims to assist healthcare professionals, screening organizations, and community programs by providing a reliable digital solution for identifying potential vision concerns and supporting timely referral pathways.

Explore Current Build

Mohan’s vision is to contribute to a future where advanced digital technologies make vision screening more accessible, efficient, and impactful worldwide. Through BODVS, he aims to support earlier identification of vision-related concerns and help connect individuals with appropriate eye care services.

Flagship INNOVATIONS

Dalton’s® Pseudo Isochromatic Plates

The world’s fastest clinically validated tool to screen colourblindness in under 6 seconds, developed, patented & trademarked by Mohan Venkadesan, has screened more than ONE MILLION + children across India and Nepal and has been deployed across major Eye care networks. Dalton’s PIP® has also been published in International Research Journal. Available across multiple formats, including Physical, Digital and AI-assisted grading approaches.

Dalton's PIP

AI based Squint Screener

Identifying the level and proximity of squint is a time consuming process today. Mohan developed an AI assisted screening technology designed to support earlier identification of strabismus and improve clinical assessment pathways.

AI Squint Screener MohanVenkadesan

Continuous Eye Disease Monitoring Solutions

Prognosis of any disease has to be monitored regularly for credible interventions from the Medics. Mohan has developed an intervention, making continuous eye health monitoring accessible

Continuous Eye Disease monitoring system by mohanvenkadesan

NIIVSU

Portable, Reliable Vision Screening Infrastructure for large-scale programmes

NIIVSU by Mohanvenkadesan

Building at the intersection of clinical expertise, healthcare innovation and scalable technology to create the next generation of preventive eye care systems

Let’s Collaborate 🤝

contact@mohanvenkadesan.com